These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Variability of mycobacterial population in the process of the experimental chemotherapy of tuberculosis. Golyshevskaya VI Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):263-6. PubMed ID: 3027864 [No Abstract] [Full Text] [Related]
4. [Use of 3H-thymidine to study the metabolism of Mycobacterium tuberculosis as changed during chemotherapy]. Golyshevskaia VI; Bibergal' EA Probl Tuberk; 1988; (10):50-3. PubMed ID: 3148133 [No Abstract] [Full Text] [Related]
5. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue]. Golyshevskaia VI; Akhunov ShB; Bibergal' EA Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201 [No Abstract] [Full Text] [Related]
6. [Systematic research on asymptomatic bacilluria in 120 non selected cases of pulmonary tuberculosis]. Favez G; Nicca B; Pressia O Schweiz Med Wochenschr; 1972 Jun; 102(25):877-80. PubMed ID: 4624459 [No Abstract] [Full Text] [Related]
7. [Effect of x-ray irradiation on the biological properties of Mycobacterium tuberculosis]. Golyshevskaia VI; Bibergal' EA Probl Tuberk; 1985; (8):53-6. PubMed ID: 3933000 [No Abstract] [Full Text] [Related]
8. [The nature of bacterial secretions in patients with focal pulmonary tuberculosis]. Il'ina TIa Probl Tuberk; 1974; (10):6-10. PubMed ID: 4213567 [No Abstract] [Full Text] [Related]
9. [Role of biological assay in the detection of "latent" bacteria release during chemotherapy]. Posperov VV; Pashkov IuN; Lobchenko AI Probl Tuberk; 1982 Aug; (8):62-6. PubMed ID: 6815644 [No Abstract] [Full Text] [Related]
10. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis]. Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651 [No Abstract] [Full Text] [Related]
11. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study]. Muratov VV; Pashkov IuN; Chukanov VI Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636 [No Abstract] [Full Text] [Related]
12. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)]. Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805 [No Abstract] [Full Text] [Related]
13. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
14. [Contagiousness of tuberculosis patients undergoing chemotherapy]. Medici TC; Rieder H Schweiz Med Wochenschr; 1981 Aug; 111(34):1252-5. PubMed ID: 6792701 [No Abstract] [Full Text] [Related]
15. [Effect of a steady magnetic field on Mycobacterium tuberculosis]. Stasiuk GA Probl Tuberk; 1974; (7):75-7. PubMed ID: 4212632 [No Abstract] [Full Text] [Related]